CEGEDIM produktové protfólio Hotel Kaskády

Size: px
Start display at page:

Download "CEGEDIM produktové protfólio Hotel Kaskády"

Transcription

1 CEGEDIM produktové protfólio Hotel Kaskády

2 Cegedim predstavenie od roku ročná skúsenosť zamestnancov priame zastúpenie v 43 krajinách sveta poskytovaná podpora vo viac ako 80 krajinách Obrat v roku 2010: 927 miliónov Euro Viac ako 600 klientov celosvetovo medicínskych zástupcov používa Cegedim 900,0 CRM % market share vo farmaceutickom priemysle celosvetovo 800 Cegedim total Sales (million ) ,0 500, ,5 389, ,0 840,0 927,

3 Cegedim SK produktové portfólio CRM riešenie (18 klientov) Mobile Intelligence, TEAMS Databáza OneKey (22 klientov) Direct mailing market leader Marketingové prieskumy recall test Compliance riešenie Xtelligence analytický nástroj ďalšie produkty 3

4 Compliance riešenie Hotel Kaskády

5 Agenda Globálne trendy a ciele Compliance Súčasný stav na Slovensku AggregateSpend360 Záver otázky 6

6 GLOBÁLNY POHĽAD - NARIADENIA V RÁMCI EU 7

7 GLOBÁLNE TRENDY 8

8 Súčasné globálne trendy + EU Druh nariadenia/ smernice Povinnosť spoločnosti Pôsobnosť Sankcie a pokuty State Laws Promotional spend reporting U.S. Financial penalties Federal Law (PPACA 6002) Promotional spend reporting and public disclosure U.S. Financial penalties ABPI (UK Pharma Assoc.) Speaker, consultant, ad board fees reporting UK Self regulation France Law Fall 2011 Spend data reporting and public disclosure France Financial penalties CGR/Nefarma (Dutch Pharma. Association) Spend data reporting and public disclosure The Netherlands Self regulation Slovakia JPMA (Japan Pharma Assoc.) Australia (Medicines Australia Assoc.) Spend data reporting and disclosure Spend data reporting and public disclosure Slovakia Japan Financial penalties Self regulation Spend data reporting Australia Self regulation UK Bribery Act Foreign Corrupt Practices Act (FCPA) Adequate anti-bribery preventive measures Clean Books of records Anti-bribery measures Global Global Financial penalties / civil and criminal prosecution Financial penalties / civil and criminal prosecution 10

9 Legislativne podmienky SR Povinnosť farmaceutickej spoločnosti alebo distribútora: Od Zoznam účastníkov lekárskych podujatí Meno Priezvisko Domáca adresa Národné centrum zdravotníckych informácií (NCHI) 13

10 Legislatívne podmienky SR Povinnosť lekára resp. zdravotníckeho poskytovateľa: Od Informovať Ministerstvo zdravotníctva 1. Peňažný alebo nepeňažný príjem 2. Názov plátcu 3. Meno príjemcu 4. Adresa zdravotníckeho zariadenia 5. Účel pre prijatie odmeny Ministerstvo zdravotníctva (MOH) 14

11 Legislativne podmienky SR Povinnosť farmaceutickej spoločnosti, distribútora liečiv...: Od Informovať Ministerstvo zdravotníctva Marketingové náklady Marketingové a nepeňažné benefity poskytnuté (HCP) na pravidelnej báze Ministerstvo zdravotníctva (MOH) 15

12 AggregateSpend360 Architecture Interná apl. ERP (SAP) T&E Automatický prenos Transparentnosť Distribúcia CRM Cestovná agentúra Integrácia, validácia a spend data management Priebežný systém varovania Preddefinované reporty Na mieru reporty Analýza dát Informovanie a odsúhlasenie prijímateľom Spend data rozposlanie Klinické štúdie Vzdelávanie Manuálny zápis alebo load súboru Denne aktualizovaná databáza lekárov, lekární a zdrav.inštitúcií s priebežnou validáciou 19

13 Ďakujem za pozornosť

Cegedim Commercial success under tough conditions. November, 9 th 2011

Cegedim Commercial success under tough conditions. November, 9 th 2011 Cegedim Commercial success under tough conditions Q3 2011 Revenue November, 9 th 2011 Safe Harbour Statement This presentation contains forward-looking statements (made pursuant to the safe harbour provisions

More information

Bribery and Corruption

Bribery and Corruption Bribery and Corruption The FCPA, UK Bribery Act, and Other Anti-Corruption Measures 2018 Association of Certified Fraud Examiners, Inc. Introduction The FCPA and the UK Bribery Act are the two premier

More information

This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private

This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private Safe Harbour Statement This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995). By their nature, forward-looking

More information

Christiana Serugová, Partner, Tax Leader at PwC Tel.:

Christiana Serugová, Partner, Tax Leader at PwC Tel.: Press Release Date 24 November 2016 Contact PwC Slovakia Christiana Serugová, Partner, Tax Leader at PwC Tel.: +421 2 59350 614 christiana.serugova@sk.pwc.com Mariana Butkovská, Marketing & Communications

More information

Any questions relating to this Methodology Note and / or the report should be directed to:

Any questions relating to this Methodology Note and / or the report should be directed to: OTSUKA PHARMACEUTICAL (UK) LTD METHODOLOGY NOTE FOR THE 2016 REPORTING YEAR Preamble In order to comply with the requirements of the ABPI Code of Practice, Otsuka agrees to document and publish details

More information

COUNTRY COMPLIANCE UPDATES

COUNTRY COMPLIANCE UPDATES COUNTRY COMPLIANCE UPDATES Indonesia Cahyani Endahayu, Associate Partner Hadiputranto, Hadinoto & Partners Transparency International 2 Transparency International Results by Country State s losses due

More information

Working Group on Bribery: 2012 Data on Enforcement of the Anti-Bribery Convention

Working Group on Bribery: 2012 Data on Enforcement of the Anti-Bribery Convention Working Group on Bribery: 2012 Data on Enforcement of the Anti-Bribery Convention Highlights from the Working Group on Bribery Enforcement Data, as of December 2012 221 individuals and 90 entities have

More information

EMERGING TRENDS IN LATIN AMERICA

EMERGING TRENDS IN LATIN AMERICA EMERGING TRENDS IN LATIN AMERICA 17 th Annual Pharmaceutical & Medical Device Compliance Congress Colleen Conry Michael Casey Partner, Ropes & Gray LLP Counsel, Ropes & Gray LLP 1 1 October 13, 2016 AGENDA

More information

Sadzobník kartových poplatkov firemné platobné karty / Schedule of Card Charges company payment cards

Sadzobník kartových poplatkov firemné platobné karty / Schedule of Card Charges company payment cards Sadzobník kartových poplatkov firemné platobné karty / Schedule of Card Charges company payment cards Citibank Europe plc., so sídlom Dublin, North Wall Quay 1, Írsko, registrovaná v registri spoločností

More information

Best Practices for Cross-Border Investigations and Due Diligence. European Compliance & Ethics Institute February 27, 2018

Best Practices for Cross-Border Investigations and Due Diligence. European Compliance & Ethics Institute February 27, 2018 Best Practices for Cross-Border Investigations and Due Diligence European Compliance & Ethics Institute February 27, 2018 Ann Sultan, Counsel, Miller & Chevalier Geza Nagy, Compliance Officer, VEON Ltd.

More information

OVERVIEW OF INTERNATIONAL ANTI-BRIBERY LAWS

OVERVIEW OF INTERNATIONAL ANTI-BRIBERY LAWS Global Investigations in an International World: Managing Investigations in the Face of a Proliferation of New Anti-Bribery Laws and Cooperation Among Governments Todd Braunstein, Willis Towers Watson

More information

Pharma Cooperation Code Transparency Report Methodological Note. Pfizer Switzerland

Pharma Cooperation Code Transparency Report Methodological Note. Pfizer Switzerland Pharma Cooperation Code Transparency Report 2017 Methodological Note Pfizer Switzerland 1. Table of Content 2. INTRODUCTION... 3 3. PFIZER ACTIVITIES PER EFPIA/SCIENCEINDUSTRIES CATEGORY... 4 4. DEFINITION

More information

OTSUKA PHARMACEUTICAL EUROPE LTD ( OTSUKA EUROPE ) EFPIA DISCLOSURE: AUSTRIA METHODOLOGY NOTE APPLICABLE TO TRANSFERS OF VALUE.

OTSUKA PHARMACEUTICAL EUROPE LTD ( OTSUKA EUROPE ) EFPIA DISCLOSURE: AUSTRIA METHODOLOGY NOTE APPLICABLE TO TRANSFERS OF VALUE. OTSUKA PHARMACEUTICAL EUROPE LTD ( OTSUKA EUROPE ) EFPIA DISCLOSURE: AUSTRIA METHODOLOGY NOTE APPLICABLE TO TRANSFERS OF VALUE FOR THE 2015 REPORTING YEAR Preamble This Methodology Note covers the disclosure

More information

Back to the Basics An End of the Year Review of the FCPA

Back to the Basics An End of the Year Review of the FCPA womblebonddickinson.com Back to the Basics An End of the Year Review of the FCPA Claire J. Rauscher Partner-Womble Bond Dickinson Charlotte, North Carolina December 12, 2017 Year End Review of the Foreign

More information

Anti-Bribery & Anti-Corruption Compliance in Russia

Anti-Bribery & Anti-Corruption Compliance in Russia Anti-Bribery & Anti-Corruption Compliance in Russia Alex Stolarsky Rechtsanwalt, Director of Legal, Tax and Compliance, Member of the Board, SCHNEIDER GROUP Veronika Kochieva Legal Team Leader, SCHNEIDER

More information

Yes Santa Claus, there is Anti-Corruption Enforcement in Canada

Yes Santa Claus, there is Anti-Corruption Enforcement in Canada Yes Santa Claus, there is Anti-Corruption Enforcement in Canada Presenter: Iris Fischer Blakes Toronto, Canada Moderator: Claire J. Rauscher Womble Carlyle Charlotte, NC Canadian Business Crimes in the

More information

The U.S. Foreign Corrupt Practices Act (FCPA):

The U.S. Foreign Corrupt Practices Act (FCPA): The U.S. Foreign Corrupt Practices Act (FCPA): The Basics, Recent Developments & How the FCPA Applies to Businesses in Thailand (and not just American businesses) 26 July 2016 Douglas Mancill PriceSanond

More information

GLOBAL BUSINESS. a series of stages that include: 1. Exporting. 4. Wholly owned subsidiaries 5. Global sourcing.

GLOBAL BUSINESS. a series of stages that include: 1. Exporting. 4. Wholly owned subsidiaries 5. Global sourcing. 8-1 8-2 GLOBAL BUSINESS AND ACCOUNTING Chapter 8 To define four mechanisms companies use to globalize their business activities. 8-3 8-4 Occurs as managers become aware of and engage in cross-border trade

More information

The Pharmaceutical Market: Did we Learned the Crisis Lessons? Petru Crăciun ZF Pharma Bucharest 2014, September 29th

The Pharmaceutical Market: Did we Learned the Crisis Lessons? Petru Crăciun ZF Pharma Bucharest 2014, September 29th The Pharmaceutical Market: Did we Learned the Crisis Lessons? Petru Crăciun ZF Pharma Bucharest 2014, September 29th The Pharmaceutical Market Pharma Market MAT(2008 - M6) MAT(2014 - M6) +/- % Total Units

More information

International Business Transactions. FCPA, OECD Convention and OECD Member States New Legislation

International Business Transactions. FCPA, OECD Convention and OECD Member States New Legislation International Business Transactions Introduction to the International Anti-bribery Laws FCPA, OECD Convention and OECD Member States New Legislation Analysis, Comparison and Risk Management A European

More information

An Overview of the Foreign Corrupt Practices Act

An Overview of the Foreign Corrupt Practices Act BEIJING BRUSSELS CHICAGO DALLAS FRANKFURT GENEVA HONG KONG LONDON LOS ANGELES NEW YORK SAN FRANCISCO SHANGHAI SINGAPORE SYDNEY TOKYO WASHINGTON, D.C. An Overview of the Foreign Corrupt Practices Act Presentation

More information

Toshifumi Ishida. International Safety and Security Cooperation Division Ministry of Foreign Affairs of Japan

Toshifumi Ishida. International Safety and Security Cooperation Division Ministry of Foreign Affairs of Japan G20 Anti-Corruption Toshifumi Ishida International Safety and Security Cooperation Division Ministry of Foreign Affairs of Japan The views expressed in this presentation do not necessarily represent the

More information

Cegedim Q Revenue Highlights th. August 3 th, 2011

Cegedim Q Revenue Highlights th. August 3 th, 2011 Cegedim Q2 2011 Revenue Highlights th August 3 th, 2011 Safe Harbour Statement This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private Securities

More information

DISCLOSURE OF TRANSFERS OF VALUE TO HEALTHCARE PROFESSIONALS AND HEALTHCARE ORGANISATIONS IN THE UK

DISCLOSURE OF TRANSFERS OF VALUE TO HEALTHCARE PROFESSIONALS AND HEALTHCARE ORGANISATIONS IN THE UK DISCLOSURE OF TRANSFERS OF VALUE TO HEALTHCARE PROFESSIONALS AND HEALTHCARE ORGANISATIONS IN THE UK METHODOLOGICAL NOTES Date of Issue: March 30 th, 2017 Country Scope: United Kingdom Version: 1.1 CONTENTS

More information

Avoiding Fraud and Corrupt Practices. Michael Steinberg IES Abroad AIEA Conference February 2014

Avoiding Fraud and Corrupt Practices. Michael Steinberg IES Abroad AIEA Conference February 2014 Avoiding Fraud and Corrupt Practices Michael Steinberg IES Abroad AIEA Conference February 2014 Types of Corruption Bribery Bribery» E Extortion Embezzlement Grey Market Avoiding Fraud and Corrupt practices

More information

Policy Debate: Perspectives on Global Device Industry Ethics & Compliance Initiatives

Policy Debate: Perspectives on Global Device Industry Ethics & Compliance Initiatives Policy Debate: Perspectives on Global Device Industry Ethics & Compliance Initiatives Moderator: Brian Sheridan Vice President,, Corporate Legal Affairs, General Counsel The Sorin Group 2013 International

More information

Anti-corruption Authorities Initiative: Survey on the Effectiveness of Anticorruption

Anti-corruption Authorities Initiative: Survey on the Effectiveness of Anticorruption Updated October, 2014 Anti-corruption Authorities Initiative: Survey on the Effectiveness of Anticorruption Background Information 1. Please enter country name in the space below NAMIBIA 2. Name of the

More information

BRIBERY IN INTERNATIONAL BUSINESS TRANSACTIONS

BRIBERY IN INTERNATIONAL BUSINESS TRANSACTIONS BRIBERY IN INTERNATIONAL BUSINESS TRANSACTIONS GLOBAL Headquarters the gregor building 716 West Ave Austin, TX 78701-2727 USA TABLE OF CONTENTS I. INTRODUCTION 1BCourse Overview... 2 94BMajor International

More information

Myanmar. Lex Mundi Global Anti-Corruption Compliance Guide. Submitted by Tilleke & Gibbins, the Lex Mundi member firm for Thailand / 27 Nov 2018

Myanmar. Lex Mundi Global Anti-Corruption Compliance Guide. Submitted by Tilleke & Gibbins, the Lex Mundi member firm for Thailand / 27 Nov 2018 Lex Mundi Interactive Guides 4_7_5 Lex Mundi Global Anti-Corruption Compliance Guide Myanmar Submitted by Tilleke & Gibbins, the Lex Mundi member firm for Thailand / 27 Nov 2018 This overview is provided

More information

NEW DUTIES OF FRENCH AN D HONG KONG COMPANIES IN LINE WITH OECD S UPSCALED STANDARD TO FIGHT AGAINST MONEY LAUNDERING WORLDWIDE 1 OUTLINE

NEW DUTIES OF FRENCH AN D HONG KONG COMPANIES IN LINE WITH OECD S UPSCALED STANDARD TO FIGHT AGAINST MONEY LAUNDERING WORLDWIDE 1 OUTLINE NEW DUTIES OF FRENCH AN D HONG KONG COMPANIES IN LINE WITH OECD S UPSCALED STANDARD TO FIGHT AGAINST MONEY LAUNDERING WORLDWIDE 1 OUTLINE French Law. - Following the European Directive 2015/849 dated 20

More information

Voya Financial Anti-Corruption and Anti-Bribery Policy

Voya Financial Anti-Corruption and Anti-Bribery Policy Voya Financial Anti-Corruption and Anti-Bribery Policy Version 2.0 April 2014 Information Sheet ISSUED BY Voya Financial Compliance OWNED AND APPROVED BY Board of Voya Financial TARGET AUDIENCE All Voya

More information

Asia-Pac Anti-Corruption Update Roundtable. Panel discussion moderated by: Chris Fordham 14 September 2017

Asia-Pac Anti-Corruption Update Roundtable. Panel discussion moderated by: Chris Fordham 14 September 2017 Asia-Pac Anti-Corruption Update Roundtable Panel discussion moderated by: Chris Fordham 14 September 2017 Panelists Chris Fordham (Moderator) Managing Partner, Asia Pacific, Fraud Investigation & Dispute

More information

The Perils Of Pharma: The Pharmaceutical Industry And The FCPA

The Perils Of Pharma: The Pharmaceutical Industry And The FCPA W O R L D - C H E C K W H I T E P A P E R The Perils Of Pharma: The Pharmaceutical Industry And The FCPA by Michael Osajda Statement of intent In recent years, the pharmaceutical industry has been subjected

More information

Foreign Corrupt Practices Act December 19, 2017

Foreign Corrupt Practices Act December 19, 2017 Foreign Corrupt Practices Act December 19, 2017 A. Katherine Toomey katherine.toomey@lbkmlaw.com Aaron T. Wolfson aaron.wolfson@lbkmlaw.com Lewis Baach Kaufmann Middlemiss PLLC Anti-Bribery and Corruption

More information

Beyond the FCPA. A Global Change in Anti-Corruption Enforcement. Presented by: Dana Choi John Irving Sonya Strnad. July 19, 2011

Beyond the FCPA. A Global Change in Anti-Corruption Enforcement. Presented by: Dana Choi John Irving Sonya Strnad. July 19, 2011 Beyond the FCPA A Global Change in Anti-Corruption Enforcement July 19, 2011 Presented by: Dana Choi John Irving Sonya Strnad Copyright 2011 Holland & Knight LLP. All Rights Reserved Global Approach to

More information

The SEC Whistleblower Law and Pharma Manufacturing in the US and Abroad Neil V. Getnick

The SEC Whistleblower Law and Pharma Manufacturing in the US and Abroad Neil V. Getnick Blowing the Whistle on cgmps: the Next Big Challenge for Compliance The SEC Whistleblower Law and Pharma Manufacturing in the US and Abroad Neil V. Getnick PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS

More information

Janssen disclosure methodology for 2015

Janssen disclosure methodology for 2015 Janssen disclosure methodology for 2015 The information below describes the methodology that Janssen has used to disclose the Transfers of Value (ToV) we have made to Healthcare Professionals (HCPs), Other

More information

Preparing for the new age of global anti-corruption enforcement Presentation to WPACC. October 15, 2013

Preparing for the new age of global anti-corruption enforcement Presentation to WPACC. October 15, 2013 Preparing for the new age of global anti-corruption enforcement Presentation to WPACC October 15, 2013 Welcome Welcome and introductions 8:30am 8:45 am Robert T. Biskup Director, Deloitte Forensic Deloitte

More information

Mitsubishi Tanabe Pharma Group Methodology. Transfers of Value to Healthcare Professionals (HCP) and Healthcare Organisations (HCO) in Europe

Mitsubishi Tanabe Pharma Group Methodology. Transfers of Value to Healthcare Professionals (HCP) and Healthcare Organisations (HCO) in Europe Mitsubishi Tanabe Pharma Group Methodology Transfers of Value to Healthcare Professionals (HCP) and Healthcare Organisations (HCO) in Europe Introduction Under the EFPIA Code on Disclosure of Transfers

More information

GDS POLICIES AND PROCEDURES FOR COMPLIANCE WITH FOREIGN CORRUPT PRACTICE ACT

GDS POLICIES AND PROCEDURES FOR COMPLIANCE WITH FOREIGN CORRUPT PRACTICE ACT GDS POLICIES AND PROCEDURES FOR COMPLIANCE WITH FOREIGN CORRUPT PRACTICE ACT Version 2016.v1 Reviewed by CEO; CFO Recommended by Audit Committee Effective Date 22 January 2017 Approved by Board of Directors

More information

EXECUTIVE COMPENSATION GROUP ADVISORY DISCLOSURE DEVELOPMENTS: EXECUTIVE COMPENSATION. Ernest W. Torain, Jr. Vedder Price P.C.

EXECUTIVE COMPENSATION GROUP ADVISORY DISCLOSURE DEVELOPMENTS: EXECUTIVE COMPENSATION. Ernest W. Torain, Jr. Vedder Price P.C. From PLI s Online Program FCPA Compliance in High Risk Jurisdictions #20434 6 EXECUTIVE COMPENSATION GROUP ADVISORY DISCLOSURE DEVELOPMENTS: EXECUTIVE COMPENSATION Ernest W. Torain, Jr. Vedder Price P.C.

More information

CORPORATE COMPLIANCE PROGRAM AND ENHANCED COMPLIANCE OBLIGATIONS

CORPORATE COMPLIANCE PROGRAM AND ENHANCED COMPLIANCE OBLIGATIONS I. CORPORATE COMPLIANCE PROGRAM 1. A clearly articulated corporate policy against violations of the FCPA, including its anti-bribery, books and records, and internal controls provisions, and other applicable

More information

Transparency & related issues Some industry considerations

Transparency & related issues Some industry considerations Transparency & related issues Some industry considerations Aline Lautenberg, Eucomed, EDMA & MedTech Europe 25 March 2014 Content Introduction Transparency & related developments Conclusion Back-up slides

More information

Disclosure Methodological Note For Aventis Pharma Ltd trading as Sanofi

Disclosure Methodological Note For Aventis Pharma Ltd trading as Sanofi Disclosure 2015 Methodological Note For Aventis Pharma Ltd trading as Sanofi INTRODUCTION The EFPIA Disclosure Code requires all EFPIA member companies to disclose transfers of value (TOV) such as support

More information

Industry Consolidation: Role of Compliance in Mergers, Acquisitions, and Divestitures

Industry Consolidation: Role of Compliance in Mergers, Acquisitions, and Divestitures Industry Consolidation: Role of Compliance in Mergers, Acquisitions, and Divestitures Prepared for CBI s Pharmaceutical Compliance Congress April 28, 2017 M&A Activity in the Pharmaceutical Industry THE

More information

REPUBLIC OF KENYA. STATEMENT Kenya Country Statement delivered during UNCAC BY

REPUBLIC OF KENYA. STATEMENT Kenya Country Statement delivered during UNCAC BY REPUBLIC OF KENYA STATEMENT Kenya Country Statement delivered during UNCAC BY HON. KENNETH LUSAKA, CBS, MP SPEAKER OF THE SENATE & LEADER OF DELEGATION 7 TH SESSION OF THE CONFERENCE OF STATES PARTIES

More information

UNITED STATES OF AMERICA Before the SECURITIES AND EXCHANGE COMMISSION

UNITED STATES OF AMERICA Before the SECURITIES AND EXCHANGE COMMISSION UNITED STATES OF AMERICA Before the SECURITIES AND EXCHANGE COMMISSION SECURITIES EXCHANGE ACT OF 1934 Release No. 83948 / August 27, 2018 ACCOUNTING AND AUDITING ENFORCEMENT Release No. 3961 / August

More information

Integrity. Bribery Act Procedures

Integrity. Bribery Act Procedures Integrity Bribery Act Procedures The risk of criminal liability for your business The Bribery Act 2010 which comes into force on 1 July 2011 creates the most onerous anti-corruption regime in the world.

More information

The Tenth International Pharmaceutical Compliance Congress Overview of the Anti-Corruption Landscape. Dr. Peter Dieners Warsaw, 10 May 2016

The Tenth International Pharmaceutical Compliance Congress Overview of the Anti-Corruption Landscape. Dr. Peter Dieners Warsaw, 10 May 2016 The Tenth International Pharmaceutical Compliance Congress Overview of the Anti-Corruption Landscape Dr. Peter Dieners Warsaw, 10 May 2016 Content General Framework International Observations and Trends

More information

High Risk Markets & FCPA

High Risk Markets & FCPA High Risk Markets & FCPA SCCE SoCal Regional Compliance & Ethics Conference January 26, 2018 Brian R. Michael Partner King & Spalding LLP Julie Myers Wood Chief Executive Officer Guidepost Solutions Tedra

More information

The First Asia Pacific Pharmaceutical Compliance Congress & Best Practices Forum

The First Asia Pacific Pharmaceutical Compliance Congress & Best Practices Forum The First Asia Pacific Pharmaceutical Compliance Congress & Best Practices Forum Overview of Asia Pacific Pharma & Device Compliance Trends Sabina Sudan Sept 2011 The Ritz-Carlton, Millenia Singapore What

More information

2017 Year-End Review: Anti-Corruption Trends and Other Corporate Enforcement Issues

2017 Year-End Review: Anti-Corruption Trends and Other Corporate Enforcement Issues 2017 Year-End Review: Anti-Corruption Trends and Other Corporate Enforcement Issues January 25, 2018 Davis Polk & Wardwell LLP CLE CREDIT AVAILABLE Agenda 2017 Facts and Figures DOJ Developments FCPA Corporate

More information

Enforcement of Foreign Bribery under the OECD Anti-Bribery Convention

Enforcement of Foreign Bribery under the OECD Anti-Bribery Convention Enforcement of Foreign Bribery under the OECD Anti-Bribery Convention Kathleen Kao Anti-Corruption Division, OECD The views expressed in this presentation do not necessarily NOT PROTECTIVELY represent

More information

BRIBE, SWINDLE OR STEAL

BRIBE, SWINDLE OR STEAL TRACE International Podcast Spotlight on the Netherlands Marike Bakker [00:00:08] Welcome back to the podcast Bribe, Swindle or Steal. I'm Alexandra Wrage and my guest today is Marike Bakker. Marike is

More information

Presentation by Economy Under Review - Viet Nam

Presentation by Economy Under Review - Viet Nam 2009/SOM2/015anx3 Agenda Item: V Presentation by Economy Under Review - Viet Nam Purpose: Consideration Submitted by: APEC Secretariat Second Senior Officials Meeting Plenary Session Singapore 19 July

More information

CARDAX, INC. FOREIGN CORRUPT PRACTICES ACT COMPLIANCE POLICY

CARDAX, INC. FOREIGN CORRUPT PRACTICES ACT COMPLIANCE POLICY CARDAX, INC. FOREIGN CORRUPT PRACTICES ACT COMPLIANCE POLICY Purpose The purpose of this Foreign Corrupt Practices Act Compliance Policy (this Policy ) is to help ensure compliance by Cardax, Inc. (the

More information

GOLD RESOURCE CORPORATION FOREIGN CORRUPT PRACTICES ACT COMPLIANCE POLICY Confirmed December 7, 2018

GOLD RESOURCE CORPORATION FOREIGN CORRUPT PRACTICES ACT COMPLIANCE POLICY Confirmed December 7, 2018 GOLD RESOURCE CORPORATION FOREIGN CORRUPT PRACTICES ACT COMPLIANCE POLICY Confirmed December 7, 2018 Gold Resource Corporation (together with its subsidiaries, the Company ) is committed to conducting

More information

Safe Harbor Statement

Safe Harbor Statement 1 Safe Harbor Statement This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995). By their nature, forwardlooking

More information

Foreign Corrupt Practices Act Policy

Foreign Corrupt Practices Act Policy I. POLICY/PURPOSE Denny s is committed to conducting its business ethically and in compliance with all applicable laws and regulations, including the U.S. Foreign Corrupt Practices Act (FCPA) and other

More information

Q PRESENTATION 13 JULY 2018

Q PRESENTATION 13 JULY 2018 Q2 2018 PRESENTATION 13 JULY 2018 Group Highlights Q2 2018 Strong growth in revenue and improved operating profit despite challenges in Danish subsidiary. Excellent performance in Norway, Sweden, Finland

More information

Anti-corruption and compliance in Russia

Anti-corruption and compliance in Russia Anti-corruption and compliance in Russia Alex Stolarsky Rechtsanwalt Director Legal, Compliance & Tax, Member of the Board 8 October, 2018 - CHAMBER OF COMMERCE AND INDUSTRY OF THE RUSSIAN FEDERATION Agenda

More information

Anti-bribery andforeign Corrupt Practices Act Policy

Anti-bribery andforeign Corrupt Practices Act Policy Anti-bribery andforeign Corrupt Practices Act Policy March 2017 1 North Second Street, Hartsville, SC 29550 US I 843 383 7000 I sonoco.com Table of Contents Scope and Purpose... 1 I FCPA Overview... 1

More information

Agenda. EFPIA Disclosure Rules - Basics Latest Developments in Transcription As of 1/15/14

Agenda. EFPIA Disclosure Rules - Basics Latest Developments in Transcription As of 1/15/14 Agenda EFPIA Disclosure Rules - Basics Latest Developments in Transcription As of 1/15/14 1 EFPIA Released its Final Disclosure Code That Binds 33 Pharmaceutical Associations And 40 Pharmaceutical Companies

More information

IMPLEMENTATION OF THE SYSTEM OF HEALTH ACCOUNTS: THE GREEK EXPERIENCE. Professor Em. L. Liaropoulos (Project coordinator)

IMPLEMENTATION OF THE SYSTEM OF HEALTH ACCOUNTS: THE GREEK EXPERIENCE. Professor Em. L. Liaropoulos (Project coordinator) MINISTRY OF HEALTH CENTER FOR HEALTH SERVICES MANAGEMENT AND EVALUATION U. OF ATHENS HELLENIC STATISTICAL AUTHORITY IMPLEMENTATION OF THE SYSTEM OF HEALTH ACCOUNTS: THE GREEK EXPERIENCE Professor Em. L.

More information

FCPA: Enforcement, Investigations and Compliance

FCPA: Enforcement, Investigations and Compliance FCPA: Enforcement, Investigations and Compliance Association of Corporate Counsel Austin Chapter October 14, 2014 Michael Marinelli, Greenberg Traurig, Austin Sandra Gonzalez, Greenberg Traurig, Austin

More information

Anti-Bribery Policy. Copyright Oceanscan All rights reserved 2012 Page 1 of 5

Anti-Bribery Policy. Copyright Oceanscan All rights reserved 2012 Page 1 of 5 Anti-Bribery Policy Copyright Oceanscan All rights reserved 2012 Page 1 of 5 Contents Page Contents...2 1.0 Overview...3 2.0 Bribery What is the Law?...3 3.0 Enforcement...5 Copyright Oceanscan All rights

More information

U.K. Bribery Act Implications for Companies Doing Business in the United Kingdom. Wednesday, 28 July 2010

U.K. Bribery Act Implications for Companies Doing Business in the United Kingdom. Wednesday, 28 July 2010 U.K. Bribery Act Implications for Companies Doing Business in the United Kingdom Wednesday, 28 July 2010 Presenters Bob Hirth is the Executive Vice President and Global Managing Director of Internal Audit

More information

G20 Finance Track. 18 Februari 2016

G20 Finance Track. 18 Februari 2016 G20 Finance Track 18 Februari 2016 1 Background "the commitment to work together to establish an informal mechanism for dialogue among systemically important countries, within the framework of the Bretton

More information

Recent FCPA Enforcement Action

Recent FCPA Enforcement Action March 2009 Recent FCPA Enforcement Action BY TIMOTHY L. DICKINSON, WILLIAM F. PENDERGAST, JENNIFER D. RIDDLE AND PAULA R. KATZ February 11, 2009, KBR, Inc. ( KBR ) reached settlements resolving criminal

More information

US Antitrust Issues Trends In Cartel Enforcement Niall E. Lynch June 20, 2011

US Antitrust Issues Trends In Cartel Enforcement Niall E. Lynch June 20, 2011 US Antitrust Issues Trends In Cartel Enforcement Niall E. Lynch June 20, 2011 Latham & Watkins operates worldwide as a limited liability partnership organized under the laws of the State of Delaware (USA)

More information

Foreign Corrupt Practices Act Policy August 16, 2017

Foreign Corrupt Practices Act Policy August 16, 2017 I. PURPOSE To provide guidelines to all officers, directors, employees, consultants and agents that are employed by the Company to ensure compliance with the Foreign Corrupt Practices Act of the United

More information

Compliance. TODAY March Meet Donna Abbondandolo

Compliance. TODAY March Meet Donna Abbondandolo Compliance TODAY March 2013 a publication of the health care compliance association www.hcca-info.org Meet Donna Abbondandolo Director of Compliance, Internal Audit & Compliance, Catholic Health Services

More information

ANTI-CORRUPTION AND ANTI-BRIBERY POLICY

ANTI-CORRUPTION AND ANTI-BRIBERY POLICY COMPLIANCE 18.0 ANTI-CORRUPTION AND ANTI-BRIBERY POLICY I. SCOPE This policy applies to all directors, officers, employees, agents, and shareholders of UHS of Delaware, Inc. (hereafter, UHS ), its subsidiaries

More information

Foreign Corrupt Practices Act. 15 February 2018

Foreign Corrupt Practices Act. 15 February 2018 Foreign Corrupt Practices Act 15 February 2018 Introduction The Foreign Corrupt Practices Act ( FCPA ), codified at 15 U.S.C. 78dd-1, et seq., has two separate parts. The antibribery provisions prohibit

More information

US FCPA and UK Bribery Act

US FCPA and UK Bribery Act US FCPA and UK Bribery Act Anand Saha - Anand.Saha@CliffordChance.com Partner, Clifford Chance São Paulo Seminar hosted by US FCPA: Overview Contains both antibribery and books & records provisions Applies

More information

Cegedim: First half is 2011 on target.

Cegedim: First half is 2011 on target. Public company with share capital of 13,336,506.43 euros Trade and Commercial Register: Nanterre B 350 422 622 www.cegedim.com First-half financial information at June 30, 2011 IFRS Regulated information

More information

Cegedim: EBITDA margin nearly stable in the first half of 2014

Cegedim: EBITDA margin nearly stable in the first half of 2014 Public company with share capital of 13,336,506.43 euros Trade and Commercial Register: Nanterre B 350 422 622 www.cegedim.com PRESS RELEASE Page 1 Quarterly Financial Information as of June 30, 2014 IFRS

More information

Jefferies 2014 Global Healthcare Conference. June 4, 2014

Jefferies 2014 Global Healthcare Conference. June 4, 2014 Jefferies 2014 Global Healthcare Conference June 4, 2014 1 Forward-Looking Statements This presentation may contain forward-looking statements as defined under U.S. federal securities laws, including statements

More information

Promoting Medical Products Globally

Promoting Medical Products Globally Promoting Medical Products Globally Handbook of Pharma and MedTech Compliance Argentina This publication is copyright. Apart from any fair dealing for the purpose of private study or research permitted

More information

Establishing an Anti-Corruption Compliance Program in Canada

Establishing an Anti-Corruption Compliance Program in Canada PUBLICATION Establishing an Anti-Corruption Compliance Program in Canada Date: August 14, 2012 Lawyers You Should Know: Henry Chang Original Newsletter(s) this article was published in: International Business

More information

Key Liabilities facing clubs Overview of Liability cover included in BASC membership DIRECTORS & OFFICERS LIABILITY BASC

Key Liabilities facing clubs Overview of Liability cover included in BASC membership DIRECTORS & OFFICERS LIABILITY BASC Key Liabilities facing clubs Overview of Liability cover included in BASC membership DIRECTORS & OFFICERS LIABILITY BASC 16TH MARCH 2013 Carole Martin Vice President - Finpro National Agenda General Liability

More information

Instant download and all chapters Test Bank Global Marketing Management 8th Edition Keegan

Instant download and all chapters Test Bank Global Marketing Management 8th Edition Keegan Instant download and all chapters Test Bank Global Marketing Management 8th Edition Keegan https://testbankdata.com/download/test-bank-global-marketingmanagement-8th-edition-keegan/ Global Marketing Management,

More information

Anti-Bribery. Statement of Policy

Anti-Bribery. Statement of Policy Policy # CMP-2-15 Page: 1 of 6 Revision History Issued By: Corporate Compliance Date Effective: Aug 31, 2010 Rev. Effective: Jun 7, 2013 Approved by: Steve F. Crooke, Jennafer Watson Contents Date Issued:

More information

Statistical annex. The digital economy 2007

Statistical annex. The digital economy 2007 Statistical annex The digital economy 2007 The statistical annex of the publication The digital economy 2007 includes several detailed tables on various subjects. This annex contains nine tables related

More information

University of California, Berkeley

University of California, Berkeley University of California, Berkeley Corruption to Good Governance: Are There Lessons from Abroad? Ken Taymor, Executive Director Berkeley Center for Law, Business & the Economy July 9, 201 1 Overview Introduction

More information

LATAM Anti-Corruption Update. Cory LaBarge Chief Compliance Officer LATAM Grunenthal Group

LATAM Anti-Corruption Update. Cory LaBarge Chief Compliance Officer LATAM Grunenthal Group LATAM Anti-Corruption Update Cory LaBarge Chief Compliance Officer LATAM Grunenthal Group Disclaimer The views and opinions expressed in this presentation are from the author and do not reflect the official

More information

Mark Bartlett Davis Wright Tremaine LLP

Mark Bartlett Davis Wright Tremaine LLP Mark Bartlett Davis Wright Tremaine LLP The Foreign Corrupt Practices Act (FCPA) prohibits corrupt payments to foreign officials for the purpose of obtaining or keeping business Mid-1970s, series of SEC

More information

ABP as a force for good

ABP as a force for good ABP as a force for good Responsible investment policy RESPONSIBLE INVESTMENT POLICY Rotterdam, October 6th 2017 Corien Wortmann Chair of the board of ABP 1 Agenda: ABP s ambition as a force for good Objectives

More information

Avoiding Anti-Corruption Missteps in a Global Market. November 30, 2017

Avoiding Anti-Corruption Missteps in a Global Market. November 30, 2017 Avoiding Anti-Corruption Missteps in a Global Market November 30, 2017 1 Presenters Cathrine Razzano Assistant General Counsel & Director, General Dynamics Kristin Robinson Associate, Bryan Cave LLP +1

More information

Transparency guidelines and disclosure payments in the pharmaceutical industry

Transparency guidelines and disclosure payments in the pharmaceutical industry Transparency guidelines and disclosure payments in the pharmaceutical industry Abstract Based on the Transparency Guidelines for the Relationship between Corporate Activities and Medical Institutions established

More information

Safe Harbor Statement

Safe Harbor Statement 1 Safe Harbor Statement This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995). By their nature, forwardlooking

More information

T.R.A.D.E. Hot Topics Bratislava, October 2017

T.R.A.D.E. Hot Topics Bratislava, October 2017 w w w. a i j a. o r g T.R.A.D.E. Hot Topics Bratislava, 12-14 October 2017 Distribution of pharmaceutical products: a changing environment? Moderator: Janine Demont (Switzerland) Speakers: Christophe Héry

More information

ANTI-CORRUPTION POLICY

ANTI-CORRUPTION POLICY ANTI-CORRUPTION POLICY 1. INTRODUCTION All of IAVI s dealings with third parties are to be carried out with the highest standards of integrity and in compliance with all relevant laws and regulations.

More information

OIL & GAS SUPPLY CHAIN: Compliance Considerations for International Energy Companies

OIL & GAS SUPPLY CHAIN: Compliance Considerations for International Energy Companies COURSE OIL & GAS SUPPLY CHAIN: Compliance Considerations for International Energy Companies October 29-30, 2018 Hyatt Regency Houston Houston, TX TAG US #EUCIEvents FOLLOW US @EUCIEvents EUCI is authorized

More information

Overview of the U.S. Foreign Corrupt Practices Act

Overview of the U.S. Foreign Corrupt Practices Act Presentation for the Swiss- American Chamber of Commerce: Overview of the U.S. Foreign Corrupt Practices Act Kevin M. King November 16, 2011 2010 Cooley LLP, Five Palo Alto Square, 3000 El Camino Real,

More information

Lessons Learned about Anti- Bribery Foreign Corrupt Practices from Recent Cases

Lessons Learned about Anti- Bribery Foreign Corrupt Practices from Recent Cases Lessons Learned about Anti- Bribery Foreign Corrupt Practices from Recent Cases Ted Acosta Ernst & Young Keith Korenchuk Covington & Burling Daniel Garen - Siemens The Global Regulatory Maze The FCPA OECD

More information

Law Amendment and the FCPA Best Practices for Responding to a Chinese Government Commercial Bribery Investigation

Law Amendment and the FCPA Best Practices for Responding to a Chinese Government Commercial Bribery Investigation Presenting a live 90 minute webinar with interactive Q&A New Chinese Anti Corruption Law Amendment and the FCPA Best Practices for Responding to a Chinese Government Commercial Bribery Investigation THURSDAY,

More information

Investment Management Institute 2017

Investment Management Institute 2017 CORPORATE LAW AND PRACTICE Course Handbook Series Number B-2310 Investment Management Institute 2017 Volume Two Co-Chairs Barry P. Barbash Paul F. Roye To order this book, call (800) 260-4PLI or fax us

More information

Methodology for Compliance with the ABPI Disclosure Code. Introduction Page 1. General Comments Page 2. Indirect Transfers of Value Page 3

Methodology for Compliance with the ABPI Disclosure Code. Introduction Page 1. General Comments Page 2. Indirect Transfers of Value Page 3 Date Published: 15 th March 2017 Version: 20 (December 4, 2015) Index Methodology for Compliance with the ABPI Disclosure Code Introduction Page 1 General Comments Page 2 Indirect Transfers of Value Page

More information

Corruption and Compliance Programs: Comparison of French and U.S. Approaches

Corruption and Compliance Programs: Comparison of French and U.S. Approaches November 2008 Corruption and Compliance Programs: Comparison of French and U.S. Approaches BY PHILIPPE BOUCHEZ EL GHOZI, JENNIFER D. RIDDLE AND CLÉMENCE AUROY The decision concerning the conclusion of

More information